DCVC Bio L.P. 13D and 13G filings for AbCellera Biologics Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-02-14 3:24 pm Sale | 2021-12-31 | 13G | AbCellera Biologics Inc. ABCL | DCVC Bio L.P. | 7,305,761 2.600% | -21,800,000 (-74.90%) | Filing |
| 2021-02-09 06:24 am Purchase | 2020-12-31 | 13G | AbCellera Biologics Inc. ABCL | DCVC Bio L.P. | 29,105,761 10.800% | 29,105,761 (New Position) | Filing |